Suppr超能文献

[高原藏族患者不同类型过敏性紫癜的相关危险因素]

[Risk factors associated with different types of Henoch-Schönlein purpura in Tibetan patients at high altitude].

作者信息

Wei Hui

机构信息

Department of Rheumatology and Immunology, Peking University Third Hospital, Beijing 100191, China.

Department of Rheumatology, Immunology and Hematology, Tibet Autonomous Region People's Hospital, Lhasa 850000, China.

出版信息

Beijing Da Xue Xue Bao Yi Xue Ban. 2023 Oct 18;55(5):923-928. doi: 10.19723/j.issn.1671-167X.2023.05.022.

Abstract

OBJECTIVE

To investigate the risk factors of different types of Henoch-Schönlein purpura (HSP) in Tibetan patients at high altitude, as to provide reference for correctly identifying high-risk patients.

METHODS

A retrospective study was used to analyze the 304 HSP patients admitted to Tibet Autonomous Region People's Hospital from April 2014 to March 2022. The gender, age, allergic history, family history, clinical type, laboratory indexes (hemoglobin, platelet count, eosinophil, C-reactive protein (CRP), albumin, immunoglobulin G, immunoglobulin A, complement C3 and C4) were analyzed retrospectively. Univariate and multivariate Logistic regression analysis to screen for risk factors affecting different types of HSP.

RESULTS

Renal HSP patients showed higher IgA [(9.2±1.7) g/L (6.4±2.4) g/L, =0.015], lower complement C3 [(203.3±21.6) mg/dL (301.1±19.5) mg/dL, =0.043], and complement C4 [(33.5±2.3) mg/dL (53.0±7.2) mg/dL, =0.032]. The patients with abdominal HSP showed lower levels of hemoglobin [(119.6±19.6) g/L (146.6±47.3) g/L, =0.038] and plasma albumin [24.8 (22.1, 33.9) g/L 32.6 (24.6, 35.1) g/L, =0.045]. The patients with articular HSP exhibited higher CRP [13.5 (0.2, 20.6) g/L 7.5 (0.1, 15.2) g/L, =0.036] and erythrocyte sedimentation rate (ESR) [24 (5, 40) mm/h 15 (4, 30) mm/h, =0.049]. Elevated IgA and decreased complement C4 were risk factors for renal HSP, anemia and decreased plasma albumin were risk factors for abdominal HSP, and elevated CRP was a risk factor for articular HSP.

CONCLUSION

The clinical characteristics of different types of HSP in plateau areas were different. Patients with high IgA, low complement C4, anemia, hypoalbuminemia, and significantly elevated CRP should be highly vigilant. Early and effective intervention can improve the clinical efficacy, avoid severe development, and improve the prognosis.

摘要

目的

探讨高原地区藏族过敏性紫癜(HSP)患者不同临床类型的危险因素,为正确识别高危患者提供参考。

方法

采用回顾性研究方法,分析2014年4月至2022年3月在西藏自治区人民医院收治的304例HSP患者。对患者的性别、年龄、过敏史、家族史、临床类型、实验室指标(血红蛋白、血小板计数、嗜酸性粒细胞、C反应蛋白(CRP)、白蛋白、免疫球蛋白G、免疫球蛋白A、补体C3和C4)进行回顾性分析。采用单因素和多因素Logistic回归分析筛选影响不同类型HSP的危险因素。

结果

肾型HSP患者的IgA水平较高[(9.2±1.7)g/L 比(6.4±2.4)g/L,P = 0.015],补体C3水平较低[(203.3±21.6)mg/dL 比(301.1±19.5)mg/dL,P = 0.043],补体C4水平较低[(33.5±2.3)mg/dL 比(53.0±7.2)mg/dL,P = 0.032]。腹型HSP患者的血红蛋白水平较低[(119.6±19.6)g/L 比(146.6±47.3)g/L,P = 0.038],血浆白蛋白水平较低[24.8(22.1,33.9)g/L 比32.6(24.6,35.1)g/L,P = 0.045]。关节型HSP患者的CRP水平较高[13.5(0.2,20.6)g/L 比7.5(0.1,15.2)g/L,P = 0.036],红细胞沉降率(ESR)较高[24(5,40)mm/h 比15(4,30)mm/h,P = 0.049]。IgA升高和补体C4降低是肾型HSP的危险因素,贫血和血浆白蛋白降低是腹型HSP的危险因素,CRP升高是关节型HSP的危险因素。

结论

高原地区不同类型HSP的临床特征存在差异。IgA升高、补体C4降低、贫血、低白蛋白血症及CRP显著升高的患者应高度警惕。早期有效干预可提高临床疗效,避免病情进展,改善预后。

相似文献

1
[Risk factors associated with different types of Henoch-Schönlein purpura in Tibetan patients at high altitude].
Beijing Da Xue Xue Bao Yi Xue Ban. 2023 Oct 18;55(5):923-928. doi: 10.19723/j.issn.1671-167X.2023.05.022.
2
[Analysis of relevant risk factors to Henoch-Schönlein purpura in Tibetan children].
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 Jun;31(6):742-745. doi: 10.3760/cma.j.issn.2095-4352.2019.06.016.
3
[Analysis of clinical characteristics of Henoch-Schonlein purpura patients from different altitudes in plateau areas].
Beijing Da Xue Xue Bao Yi Xue Ban. 2021 Dec 18;53(6):1072-1077. doi: 10.19723/j.issn.1671-167X.2021.06.011.
4
Characteristics of immune function in the acute phase of Henoch-Schönlein purpura.
Clin Rheumatol. 2021 Sep;40(9):3711-3716. doi: 10.1007/s10067-021-05707-6. Epub 2021 Mar 29.
5
Clinical significance of the serum biomarker index detection in children with Henoch-Schonlein purpura.
Clin Biochem. 2018 Feb;52:167-170. doi: 10.1016/j.clinbiochem.2017.11.006. Epub 2017 Nov 10.
6
Proteome analysis reveals novel serum biomarkers for Henoch-Schönlein purpura in Chinese children.
J Proteomics. 2023 Mar 30;276:104841. doi: 10.1016/j.jprot.2023.104841. Epub 2023 Feb 14.
7
Comparison of clinical, pathological and long-term renal outcomes of children with Henoch-Schonlein purpura nephritis and IgA nephropathy.
Int Urol Nephrol. 2022 Aug;54(8):1925-1932. doi: 10.1007/s11255-021-03063-7. Epub 2021 Nov 30.
8
[Clinical Significance of Serum Midkine in Children with Henoch-Schonlein Purpura].
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017 Feb;25(1):181-185. doi: 10.7534/j.issn.1009-2137.2017.01.032.
9
Risk Factors Associated with Renal Involvement in Childhood Henoch-Schönlein Purpura: A Meta-Analysis.
PLoS One. 2016 Nov 30;11(11):e0167346. doi: 10.1371/journal.pone.0167346. eCollection 2016.
10
Serum amyloid A levels associated with gastrointestinal manifestations in Henoch-Schönlein purpura.
Inflammation. 2012 Aug;35(4):1251-5. doi: 10.1007/s10753-012-9435-8.

本文引用的文献

1
[Analysis of clinical characteristics of Henoch-Schonlein purpura patients from different altitudes in plateau areas].
Beijing Da Xue Xue Bao Yi Xue Ban. 2021 Dec 18;53(6):1072-1077. doi: 10.19723/j.issn.1671-167X.2021.06.011.
2
Henoch-Schönlein Purpura (IgA Vasculitis): Rapid Evidence Review.
Am Fam Physician. 2020 Aug 15;102(4):229-233.
3
The Clinicopathological Characteristics of Henoch-Schönlein Purpura Nephritis with Presentation of Nephrotic Syndrome.
Kidney Blood Press Res. 2019;44(4):754-764. doi: 10.1159/000501459. Epub 2019 Aug 6.
4
Urinalysis monitoring in children with Henoch-Schönlein purpura: Is it time to revise?
Int J Rheum Dis. 2019 Jul;22(7):1271-1277. doi: 10.1111/1756-185X.13552. Epub 2019 Mar 21.
5
MEFV gene mutations in children with Henoch-Schönlein purpura and their correlations-do mutations matter?
Clin Rheumatol. 2019 Jul;38(7):1947-1952. doi: 10.1007/s10067-019-04489-2. Epub 2019 Mar 2.
6
The clinical spectrum of Henoch-Schönlein purpura in children: a single-center study.
Clin Rheumatol. 2019 Jun;38(6):1707-1714. doi: 10.1007/s10067-019-04460-1. Epub 2019 Feb 8.
7
Clinical and Pathological Characteristics of Elderly Japanese Patients with IgA Vasculitis with Nephritis: A Case Series.
Intern Med. 2019 Jan 1;58(1):31-38. doi: 10.2169/internalmedicine.1379-18. Epub 2018 Aug 10.
8
Henoch-Schönlein purpura nephritis: initial risk factors and outcomes in a Latin American tertiary center.
Clin Rheumatol. 2018 May;37(5):1319-1324. doi: 10.1007/s10067-017-3972-3. Epub 2018 Jan 13.
9
Henoch-Schönlein Purpura: A Literature Review.
Acta Derm Venereol. 2017 Nov 15;97(10):1160-1166. doi: 10.2340/00015555-2733.
10
Clinical outcomes in children with Henoch-Schönlein purpura nephritis without crescents.
Pediatr Nephrol. 2017 Jul;32(7):1193-1199. doi: 10.1007/s00467-017-3604-9. Epub 2017 Feb 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验